Skip to content

Clinical trials

Disruptive, Impulse Control, and Conduct Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disruptive, Impulse Control, and Conduct Disorders Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20031
20063
20071
20093
20112
20121
20131
20141
20162
20181
20191
20211
20221
20232
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting7
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Chicago7
Ohio State University5
University of Minnesota3
Boehringer Ingelheim2
Massachusetts General Hospital2
Azevan Pharmaceuticals1
Duke University1
M.D. Anderson Cancer Center1
NYU Langone Health1
New York State Psychiatric Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disruptive, Impulse Control, and Conduct Disorders31
Borderline Personality Disorder3
Parkinson Disease3
Trichotillomania3
Anxiety Disorders2
Attention Deficit Disorder with Hyperactivity2
Compulsive Sexual Behavior Disorder2
Excoriation Disorder2
Gambling2
Obsessive-Compulsive Disorder2

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.